U
SRGA

UBS’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

UBS’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$98K Buy
683
+356
+109% +$51.6K ﹤0.01% 6026
2014
Q2 		$43K Buy
327
+112
+52% +$14.2K ﹤0.01% 7074
2014
Q1 		$26K Sell
215
-82
-28% -$8.88K ﹤0.01% 7760
2013
Q4 		$32K Sell
297
-242
-45% -$23.5K ﹤0.01% 7568
2013
Q3 		$61K Buy
539
+66
+14% +$7.49K ﹤0.01% 6611
2013
Q2 		$53K Buy
+473
New +$57.8K ﹤0.01% 6658

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS's SRGA Position: Q3 2014 in Review

UBS increased its Surgalign Holdings, Inc. Common Stock (SRGA) stake by 109% in Q3 2014, buying an estimated $51.6K and bringing the position to 683 shares worth $98K. The position accounts for ﹤0.01% of the portfolio, ranked #6026.

UBS first reported a position in SRGA in Q2 2013 and has held it in 6 quarters since. 100 funds tracked by Wall St. Rank hold SRGA as of Q3 2014.

  • UBS held 683 shares of Surgalign Holdings, Inc. Common Stock worth $98K as of Q3 2014.
  • UBS bought 356 Surgalign Holdings, Inc. Common Stock shares in Q3 2014, an estimated $51.6K.
  • Surgalign Holdings, Inc. Common Stock made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6026 holding.
  • UBS first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and has held it in 6 quarters since.
  • 100 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.